business · 2026-06-30
India's Startup Funding Dips 9% in H1
a1ee76ae-c1e7-4da9-be40-acca3e8e1aaf
Indian startups raised $5.2Bn across 501 deals in H1 2026, down 9% in value from H1 2025 but up 7% in deal count.Only 4 rounds exceeded $100Mn versus 11 last year, signaling a shift from mega-rounds to smaller, disciplined checks across more startups.Late-stage startups saw funding drop 27% to $2.2Bn, while growth-stage companies gained 15% to $2.3Bn, reshaping which founders get capital.
Why did mega-rounds collapse from 11 to just 4?
Global LPs grew cautious on emerging markets amid higher cost of capital and geopolitical tensions. Only Spinny ($170Mn), KreditBee ($280Mn), Rapido ($240Mn), and Sarvam ($234Mn) crossed $100Mn. The median late-stage check size plunged 68% to $10Mn, showing investors refused to underwrite capital-intensive bets at peak valuations.
What made LPs cautious on late-stage Indian bets?
Global interest rates remain elevated, raising LPs' hurdle rates for illiquid VC commitments. Emerging-market allocations face extra scrutiny because currency risk compounds lower liquidity. For context, US 10-year yields near 4.5% make risk-free returns competitive with venture IRRs, so LPs demand stronger proof before committing to late-stage Indian rounds.
How did late-stage check sizes fall 68%?
Late-stage median checks dropped from ~$31Mn to $10Mn. Investors shifted from pre-IPO valuation markups toward demanding profitability proof. After 2021-22 exuberance, companies like Byju's showed how capital-intensive bets can unravel. Funds now write smaller checks with milestone-based tranches, releasing capital only when unit economics targets are met.
Did any sector still attract large rounds?
AI emerged as one bright spot. Sarvam raised $234Mn for its AI platform. Fintech also held up, with KreditBee's $280Mn round. But mobility (Rapido, Spinny) dominated the $100Mn-plus list. The pattern suggests investors still fund large rounds for companies with clear revenue models, not speculative growth stories.
Could this shift actually help more founders?
Deal count rose 7% to 501, meaning more founders received checks even as total capital shrank. The median ticket stayed steady at $3Mn. IvyCap's Vikram Gupta called it "structural maturity": more companies funded at rational valuations with stronger unit economics. Growth-stage deal volume surged 33% to 190 transactions, spreading capital wider.
Does wider deal spread reduce startup quality?
Not necessarily. With median ticket steady at $3Mn, investors are selecting more companies but applying stricter filters on unit economics. IvyCap's Gupta noted stronger fundamentals across funded startups. The exit of "tourist capital" (short-term speculators) means remaining investors conduct deeper diligence. Quality may actually improve as casual investors leave.
How does India compare to Southeast Asia now?
India raised $5.2Bn in H1 versus Southeast Asia's estimated ~$3Bn combined. Indonesia's startup funding fell ~30% over the same period. India's 501-deal volume dwarfs regional peers. The gap reflects India's deeper domestic market, a consumer base 5x Indonesia's, and a more mature VC infrastructure with over 1,100 active investors.
What happens when these startups need Series C?
A potential funding gap looms at Series C and beyond, since late-stage capital fell 27%. Companies graduating from growth-stage will face a narrower pool of large-check writers. Historically, Indian startups like Swiggy bridged this by tapping crossover funds (Softbank, Prosus). If IPO markets stay active, some may skip late rounds entirely and list directly.
Which growth-stage startups gained most?
Growth-stage startups, typically Series A and B companies, captured $2.3Bn, up 15% YoY. Late-stage startups absorbed the biggest hit, with funding falling 27% to $2.2Bn. Over 1,100 investors actively backed startups in H1, and ~64% of institutional investors plan to increase VC allocation over the next 18 months.
Which sectors attracted the 190 growth deals?
AI, fintech, and SaaS led growth-stage deal volume. AI startups benefited from global enterprise demand for India-built models. Fintech remains resilient because India's digital payments infrastructure (UPI processed 18Bn+ transactions in Q1 2026) provides a ready distribution layer. Climate-tech and healthtech also saw rising Series A activity.
How do growth-stage valuations compare to 2022?
Growth-stage valuations have corrected ~40-50% from 2021-22 peaks. A Series B that commanded 40x revenue multiple then now trades at 15-20x. For example, a SaaS company doing $10Mn ARR might raise at $150-200Mn valuation today versus $400Mn in 2021. This reset actually benefits new investors, who enter at prices closer to fundamental value.
Will 64% of investors really increase VC bets?
The 64% figure comes from Inc42's institutional investor survey. However, intent doesn't always convert to deployment. LP commitment cycles run 12-18 months, and geopolitical shocks can freeze allocations mid-cycle. A useful benchmark: after similar survey optimism in 2022, actual deployment lagged projections by ~30% due to the funding winter. Execution depends on macro stability.
Source: inc42.com